Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Lyxor Research: More upside in 2013 for hedge funds

Wednesday, July 17, 2013
Opalesque Industry Update - The remainder of 2013 is setting up for further gains and hedge funds are positioned to take advantage of the opportunities. The US economy is expanding steadily and growth will likely accelerate in the 2nd half of the year as fiscal restraint wears off. Markets have digested the higher move in bond yields and any further rise in yields will occur because of firmer economic data.

Central banks globally are almost unanimously dovish which should translate into asset reflation and easy financial conditions. The Bank of England and European Central Bank were the latest banks to use “lower for longer” language to drive down interest rates. Chairman Bernanke has also indicated that the Fed will hold rates at the current 0% level for the foreseeable future.

At the same time, economic data is improving. High velocity indicators in Europe such as PMI are increasing from a dip in 1Q and broad data in the US such as jobs, spending and production are also suggesting the economy is improving.

The volatility spike and risk aversion in June presents an attractive entry point and opportunity going forward. Risk premium increased because of higher rates and concerns about emerging markets. Both of these issues have stabilized. Bond yields in the US have repriced sharply since May but the pace of the increase will likely slow going forward. China concerns have also dissipated as the authorities introduced more liquidity into the market. We expect risk premium normalization to continue which translates into higher asset prices.

Equities are our favorite asset class and a key beneficiary of asset . Based on our metrics, equities are significantly more attractively valued than other assets at this stage in the cycle. Within equities, Japan is our most overweight region because it offers the best upside given the size of central bank stimulus and attractive valuation.

In our Alternative Strategies ranking, we have an overweight bias to directional strategies in the equity space. L/S Equity discretionary and systematic neutral strategies should benefit from a high dispersion, low volatility environment. We upgraded Long term CTAs to slight overweight after a challenging 2Q because we believe the factors responsible for the soft performance, such as a spike in rates, will be more benign going forward. On the credit side, the market appears richly valued and we downgraded L/S credit to neutral. We advocate focusing on relative value funds in the credit space with limited interest rate risk.. Based on our metrics, equities are significantly more attractively valued than other assets at this stage in the cycle. Within equities, Japan is our most overweight region because it offers the best upside given the size of central bank stimulus and attractive valuation.

In our Alternative Strategies ranking, we have an overweight bias to directional strategies in the equity space. L/S Equity discretionary and systematic neutral strategies should benefit from a high dispersion, low volatility environment. We upgraded Long term CTAs to slight overweight after a challenging 2Q because we believe the factors responsible for the soft performance, such as a spike in rates, will be more benign going forward. On the credit side, the market appears richly valued and we downgraded L/S credit to neutral. We advocate focusing on relative value funds in the credit space with limited interest rate risk.

References:
Lyxor AM, Cross Asset Research, Third Quarter 2013, www.lyxor.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for